cp wire

CP Wire Articles

Merck Announces Data from Ph III Study of Investigational HIV Therapy Doravirine
  • At Week 96, 73.1 percent of the treatment group achieved viral suppression
  • Previously reported - at week 48 DOR met its primary efficacy endpoint of non-inferiority compared to DRV+r... read more
Tue, 07/24/18 - 09:55 am
Gilead Announces Data on Truvada for HIV Prophylaxis
  • States with highest use of Truvada for PrEP had significant declines in HIV diagnoses
  • States with the lowest use saw increases in HIV diagnoses
  • Truvada was approved for HIV... read more
Tue, 07/24/18 - 09:43 am
Microbiome Report for the week ending 7-21-18

SkinBioTherapeutics receives provisional... read more

Mon, 07/23/18 - 04:49 pm
[sponsored] How to Use Speaker Book's Filters to Track Financial Disclosures

Speaker Book is an application that provides a network of doctors’ financials payments from pharmaceutical companies. In this tutorial, we will be demonstrating how to understand and navigate the... read more

Mon, 07/23/18 - 04:38 pm
Immunicum AB Announces FDA Approval to Expand Ph Ib/II trial of Cancer Drug
  • Ph II study will include up to 150 patients
  • The study will include testing in head and neck cancer, non-small cell lung cancer and gastric and gastroesophageal junction... read more
Mon, 07/23/18 - 09:57 am

Pages